Commercialization: Page 35
-
PharmaVoice Team/PharmaVoice
Attention: Outdated Access Services Strategies Actually Reduce Access
Access services aim to solve almost everything that interferes with the progression from writing prescriptions to the patients receiving their medications. Traditional emphasis has been on reimbursement barriers, solving for coverage issues as well as affordability issues. Many also include patie...
By Nora Tsvigas • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Pharma's New Organized Customers…Can We Connect the Dots?
Healthcare reform is rapidly moving to value-based reimbursement, prompting institutions and providers to join together and create new organizations capable of coordinating the care necessary to achieve value-based outcomes. These are the new pharma industry’s B2B customers: organized groups of i...
By John W. Draper • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Speak Out
A Fearless look at a workshop worth its salt When was the last time you attended a workshop or training session that felt worth the volume of unopened email and loss of billable work time? We often spend workshops checking our phones and sneaking peeks at the agenda to see when the next coffee br...
By Tara Bernardino • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
What's New
The Bloc Launches BlocAlley Trending now: New division helps drive commercial success for entrepreneurial health organizations. The Bloc has launched BlocAlley, a new division that helps clients in the health sector launch and commercialize themselves as well as their lead products and services. ...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
Pharma Trax
Biopharma Sponsors Sell or Plan to Sell Biosimilar Products Trending now: Industry experts project there will be a biosimilar boom. The majority of companies with a large molecule offering plan to enter or are already involved in the biosimilar market, including companies with no internal manufa...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
Who's On The List by Section
This article contains the list of 100 honorees. If you want to read the article featuring a particular person, please view the Section in which he/she is featured. Commanders & Chiefs Julie Adrian Chandler Chicco Agency, inVentiv Health Mary Anderson Ogilvy CommonHealth Medical Educatio...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
The Commanders & Chiefs
John W. Hubbard, Ph.D. Title: President and CEO Company: Bioclinica Education: Ph.D., Physiological Psychology and Physiology, University of Tennessee Family: Wife of 36 years Hobbies: Martial Arts, 3rd Degree Black Belt and senior instructor, international travel, home improvements, and gardenin...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
Born Leaders A Global Perspective
This year, the homelands of the PharmaVOICE 100 account for almost 20 different countries or territories — from Russia to the West Indies, from Scotland to New Zealand, and from the United States to Australia and various points in between. Six of our honorees — Ken Keller, Stu Libby, Jennifer Mat...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
The Entrepreneurs
Susan Flinn Cobian Title: Executive VP, Managing Director Company: HYC Health Education: BA, Kenyon College Family: Husband, Randy Robert Cobian Hobbies: Golf and paddle tennis Bucket List: To spend two weeks in Ireland and Scotland playing golf; to sing on the stage of the Grand Ole Opry; to com...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
Bucket List
The PharmaVOICE 100 honorees have a wide range of interests. They are interested in travel, adventure, and giving back. Download PDF
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
Change Agents
Alison Little Title: Principal, Advisory Industry Leader for Life Sciences Company: KPMG LLP Education: BS, Materials Science & Engineering, Johns Hopkins University Family: Parents; husband; two children Hobbies: Cooking, yoga, spending time with family and friends Bucket List: Travel with f...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
Alternate Universe
We asked the PharmVOICE 100 what other profession they would like to attempt. Our honorees have some fanciful and aspirational alter egos in terms of alternate professions they would, if they could, try. Download PDF
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
The Creatives
Jeffrey Perino Title: Head of Creative, Copy Company: Triple Threat Communications Education: BA, Philosophy, Loyola University; MFA, Creative Writing, Emerson College Family: Wife, Ashley; children, Michael, Julia, and Will Hobbies: Running, reading, listening to and playing classical music Soci...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
The Marketers
Michelle Petroff Title: Senior VP, Account Service and Operations Company: Fingerpaint Education: BS, Health Policy and Administration, Pennsylvania State University Family: Her husband and her two young boys who inspire her every day Hobbies: Reading, occasional jogging, photography Awards/Honor...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
Giving Back
The PharmaVOICE 100 honorees share a sincere desire to pay it forward. Philanthropy is a big part of what makes our inspired leaders tick. They generously give of their time and resources. Download PDF
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
The Challenges Facing Pharmaceutical Leaders
The pharmaceutical industry is at an unprecedented time in its evolution. Our PharmaVOICE 100 say the shifting influences of the patient, the payer, and technology are changing how medicines are developed and how care is delivered. The convergence of mobile technologies, diagnostics, and personal...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
The Innovation Spark Catches Fire
Medical innovation can help patients live longer, healthier, and more productive lives. Innovative medicines developed by America’s biopharmaceutical research companies have helped increase childhood cancer survival rates from 58% in 1970 to 83% today and have contributed to declining death rates...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
mHealth
Baxter Strives to Improve Health of Women and Children in India via Mobile App Trending now: Pharma continues to support patients through mobile services. Baxter and the Baxter International Foundation, in conjunction with Bangalore’s Health Department and World Vision India, has launched a mobi...
By PharmaVoice Team • June 1, 2016 -
PharmaVoice Team/PharmaVoice
Pharma Trax
Surge in Biosimilars to Drive Significant Change in Health System Costs Trending now: Sustainable competitive markets and support for innovation, clinical education, and incentives are needed to deliver full value. Greater acceptance of biosimilar medicines in a growing number of therapy areas a...
By PharmaVoice Team • June 1, 2016 -
PharmaVoice Team/PharmaVoice
What's New
SBP and GSK Create Center for Translational Neuroscience Trending now: Academic-industry alliance seeks to find and validate new targets for drug development. Sanford Burnham Prebys Medical Discovery Institute (SBP), a fundamental and translational research institute, and GlaxoSmithKline (GSK), ...
By PharmaVoice Team • June 1, 2016 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
Ogilvy CommonHealth Worldwide Launches the Ogilvy CommonHealth Marketing Cloud Trending Now: New service redefines data-driven marketing services for the life-sciences industry. Ogilvy CommonHealth Worldwide, the health behavior change specialists of Ogilvy & Mather, and a WPP company, has l...
By PharmaVoice Team • June 1, 2016 -
PharmaVoice Team/PharmaVoice
The Calendar
Coming Attractions The inaugural Rational Combinations 360° — June 23 – 24, 2016 Park Lane Hotel, New York, NY — is the only event addressing business aspects, novel clinical trial designs, and scientific developments for combination immunotherapies. With promising cancer immunotherapies in the c...
By PharmaVoice Team • June 1, 2016 -
PharmaVoice Team/PharmaVoice
Last Word
Patient-Centricity: More than a Catch Phrase John McCarthy, VP of Global Commercial Excellence at AstraZeneca, talks about why putting patients first should be a core focus of the biopharma industry. PV: How is AstraZeneca addressing the trend of patient-centricity? McCarthy: Patient-centricity c...
By John McCarthy • June 1, 2016 -
PharmaVoice Team/PharmaVoice
Data Analytics Create Better Commercial Strategies
The pharmaceutical industry is not immune to the glut of data being generated by medical records, social media, and connected medical devices. It cannot ignore the possibilities that these big data sets can bring to the commercial strategy table. The time is now to embrace the myriad amounts of c...
By PharmaVoice Team • June 1, 2016 -
PharmaVoice Team/PharmaVoice
Mobile Technology Increases Patient Engagement
More than 60% of smartphone users used their mobile device to search for information about a health condition, according to Pew Research Center. The analysts at eMarketer have forecast that pharma digital ad spending will rise to $2.55 billion by 2019. This growing evolution in digital applicatio...
By Robin Robinson • June 1, 2016
Previous
